Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy (AST015)

This study is ongoing, but not recruiting participants.

Study NCT00558038 Information provided by Ocera Therapeutics

First Received: November 9, 2007 Last Updated: March 19, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Hepatic Encephalopathy

Additional conditions recognized in this trial

Brain Damage, Chronic
Delirium
Encephalitis
Neurotoxicity Syndromes

Interventions listed in this trial

AST-120
lactulose

More general drug interventions related to this trial

Gastrointestinal Agents
Pharmacologic Actions
Therapeutic Uses

Sponsors listed in this trial

Ocera Therapeutics

Back to top of Main Content